Year: 2025

TomTom’s net-zero emissions reduction targets validated by the Science Based Targets initiative (SBTi)TomTom’s net-zero emissions reduction targets validated by the Science Based Targets initiative (SBTi)AMSTERDAM, Dec. 18, 2025 (GLOBE NEWSWIRE) — TomTom (TOM2), the specialist in mapping and location technology, today announced that its near-term and long-term science-based greenhouse gas (GHG) emissions reduction targets have been validated by the Science Based Targets initiative (SBTi). This validation confirms that TomTom’s decarbonization pathway is aligned with the latest climate science and consistent with achieving net-zero emissions. SBTi validation marks a significant milestone in TomTom’s long-term commitment to environmental stewardship. It reflects the company’s broader sustainability strategy and supports...

LONG BEACH, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched the STP-S30 mission for the U.S. Space Force’s (USSF) Space Systems Command (SSC) – completing the launch five months ahead of schedule and playing a critical role in advancing technologies that ensure U.S. superiority in space.    The launch, named ‘Don’t Be Such A Square’, lifted off from Rocket Lab Launch Complex 2 (LC-2) at the Mid-Atlantic Regional Spaceport (MARS) on Wallops Island, Virginia on December 18 at 12:03 a.m. (05:03 UTC) to deploy four DiskSat spacecraft to a 550km low Earth orbit for Department of War’s (DoW) Space Test Program (STP). Managed by SSC’s System Delta 89 (SYD 89) Capability Development Branch led...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present the Company’s latest developments and outlook for 2025 at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15 in San Francisco, CA, USA. Chief Executive Officer Patrick Amstutz will present on Thursday, January 15 at 10:30AM-11:10AM PT (19:30-20:10 CET) at the Westin St. Francis San Francisco, CA, USA. A webcast will be accessible on the Molecular Partners website, under the Events tab. About Molecular Partners AG Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech...

Oslo, 18 December 2025 – DNO ASA, the Norwegian oil and gas operator, today announced that it has placed its North Sea oil production with subsidiaries of Exxon Mobil Corporation and Shell plc effective 1 January 2026 and secured related offtake financing facilities for up to USD 410 million.   The agreement with ExxonMobil Asia Pacific Pte. Ltd., covering around half of DNO’s North Sea oil output, has a tenor of two years and a related revolving credit facility of up to USD 185 million. The agreement with Shell Trading and Shipping Company Limited (STASCO), covering the other half of the output, has an initial tenor of one year and a related prepayment facility with a European bank of up to USD 225 million.  “The offtake agreements with Exxon Mobil and Shell unlock considerable financing at very attractive rates, creating opportunities...

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Dec. 18, 2025 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) updated corporate developments related to the spin out of its Quebec assets (the “Quebec Spinout”) and the PX Energy transaction. Quebec Spinout The Company reported that a Special Meeting of Shareholders (the “Meeting”) is scheduled for January 15, 2026, to i) elect the Board of Directors for the Company and ii) to approve an amendment to the Company’s Articles for the Quebec Spinout. A copy of the management information circular (the “Information Circular”) prepared for the purposes of the Meeting is available on SEDAR+ in Canada and Newsweb in Norway. The...

VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and data center technology company, announces it will release audited financial results for its fourth quarter and full year 2025 ending September 30 on December 18, 2025 before the market open. Fourth Quarter and Full Year 2025 Results Conference Call Details The Company will host a conference call to review its results and provide a corporate update on December 18, 2025 at 4:30 PM ET. Participants should register for the call via the link. In addition to a live Q&A session via chat, management will also address pre-submitted questions. Those wishing to submit a question may do so via email at investors@dmgblockchain.com,...

BEIJING, Dec. 17, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) to conduct a Phase II/III clinical trial of novel TYK2 inhibitor soficitinib (ICP-332) for the treatment of chronic spontaneous urticaria (CSU). Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The current indications under development are strategically positioned within the vast dermatology market, including atopic dermatitis, vitiligo, prurigo nodularis, CSU, and more. TYK2 plays a key role...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Dec. 17, 2025 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Reeflex Solutions Inc. (TSXV: RFX), please note the date in the fourth paragraph has been corrected. The corrected release follows:  Reeflex Solutions Inc. (TSXV: RFX) (“Reeflex” or the “Company”) announces that it will be unable to meet the December 29, 2025 filing deadline (the “Filing Deadline”) for its audited annual financial statements, accompanying management’s discussion and analysis (“MD&A”) and CEO and CFO certifications (the “Certificates”) for the financial year ended August 31, 2025 (collectively, the “Annual Filings”), The Corporation further announces that it intends to restate its interim financial statements...

TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through a series of transactions ending in recent weeks (the “Dispositions”), ThreeD disposed of ownership and control of an aggregate of 1,130,000 common shares (the “Subject Shares”) of Avicanna Inc. (the “Company” or “AVCN”). The Subject Shares represented approximately 1.0% of all issued and outstanding common shares of AVCN. As a result of the Dispositions, the percentage ownership held by ThreeD and Sheldon Inwentash (the “Joint Actor”) decreased by greater than 2%, on a partially diluted basis, from the last early warning report filed. Immediately prior to the Dispositions,...